Results 121 to 130 of about 302,595 (156)
Some of the next articles are maybe not open access.
An early pop-up mpox vaccine clinic
Journal of the American Association of Nurse Practitioners, 2023ABSTRACT Mpox, formerly known as monkeypox, emerged as a viral zoonotic disease in 2022. The World Health Organization (WHO) declared a global pandemic in July 2022. Through the U.S. Food and Drug Administration's emergency use authorization, JYNNEOS became the dominant vaccine for prevention of mpox.
Rodney W. Hicks, Christopher Blackwell
openaire +2 more sources
Vaccines for Mpox — An Unmet Global Need
NEJM EvidenceIn 1970, the first case of mpox (formerly known as monkeypox) was documented in an infant in Equateur Province, Democratic Republic of Congo (DRC).1 Infections with clade I monkeypox virus (MPXV) are endemic in the rainforest regions of central Africa and result from both zoonotic and human-to-human transmission.
Lori E, Dodd +2 more
openaire +2 more sources
Mpox emergence and new vaccines: a story of susceptibility
Current Opinion in ImmunologyMpox is a smallpox-like disease caused by the monkeypox virus. In 2022, a global outbreak of mpox resulted in more than 113 000 cases. Just a year later, a different strain of mpox caused the largest ever outbreak in Africa, with over 46 000 cases. Previous mpox epidemics were small, primarily occurred in Africa, had a case-fatality rate of 1-10%, and ...
Samuel D Stampfer +2 more
openaire +2 more sources
Mpox after vaccination: a case series
Sexually Transmitted Infections, 2023Inês Aparício Martins +3 more
openaire +2 more sources
Disaster Medicine and Public Health Preparedness
Abstract Objective 2022 - 2023 mpox outbreak necessitated rapid distribution of JYNNEOS vaccines from US Strategic National Stockpile to state and local public health agencies. New Hampshire’s centralized public health structure required partnering with healthcare facilities to reach at-risk persons.
HeeEun Kang +5 more
openaire +2 more sources
Abstract Objective 2022 - 2023 mpox outbreak necessitated rapid distribution of JYNNEOS vaccines from US Strategic National Stockpile to state and local public health agencies. New Hampshire’s centralized public health structure required partnering with healthcare facilities to reach at-risk persons.
HeeEun Kang +5 more
openaire +2 more sources
AIDS Education and Prevention
During the 2022 mpox outbreak, some LGBTQ+ populations in the United States experienced elevated risk, yet motivations for mpox vaccination remain unclear. This study examined whether mpox vaccination intent/uptake was associated with uptake or intent to vaccinate for other sexually transmitted vaccine preventable diseases (VPDs), including a future ...
Stephan, Scrofani +6 more
openaire +2 more sources
During the 2022 mpox outbreak, some LGBTQ+ populations in the United States experienced elevated risk, yet motivations for mpox vaccination remain unclear. This study examined whether mpox vaccination intent/uptake was associated with uptake or intent to vaccinate for other sexually transmitted vaccine preventable diseases (VPDs), including a future ...
Stephan, Scrofani +6 more
openaire +2 more sources
Vaccine Effectiveness against Mpox in the United States
New England Journal of Medicine, 2023Nicholas P, Deputy +2 more
openaire +3 more sources
Mpox Vaccine Hesitancy Among Sexually Active People with HIV in Care at Risk for mpox
AIDS and BehaviorMpox has particularly adverse effects among people with HIV (PWH). We examined mpox vaccine utilization and hesitancy among men who have sex with men (MSM), and transgender women (TW) in HIV care in a multisite U.S. cohort. We queried MSM/TW reporting past 3-month sexual activity at 7 Centers for AIDS Research Network of Integrated Clinical Systems ...
R. J. Fredericksen +21 more
openaire +2 more sources
Breakthrough Infections After Postexposure Vaccination Against Mpox
New England Journal of Medicine, 2022Michael Thy +2 more
exaly